Orthocell has positive tennis elbow result
Orthocell has been featured in The Australian’s Business Spectator, following the release of new positive results from a study of our tendon cell treatment for tennis elbow.
Orthocell has been featured in The Australian’s Business Spectator, following the release of new positive results from a study of our tendon cell treatment for tennis elbow.
The Australian has featured news of Orthocell’s Australian Research Council grant to continue its tendon research.
Following our recent patent announcement, the Australian Financial Review has featured Orthocell in its Market Wrap.
The Australian newspaper has featured news of Orthocell’s listing on the ASX.
Details of Orthocell’s upcoming launch on the ASX has been featured in the Australian Financial Review (AFR).
Orthocell’s plans to list on the Australian Stock Exchange (ASX) have been featured in The Australian newspaper.
Jill Margo, Health Editor at the Australian Financial Review, has published a feature article on Orthocell’s innovative autologous tenocyte implantation (ATI) therapy.